Among them, oligopeptide I-C-F-6 has been proved to have a antifibrosis effect in the animal model of liver fibrosis, the mechanism of which is related to modulating NF-kB and Wnt/b-catenin signaling [32]. This evidence concerns the gene NFKB1 and Hepatic fibrosis.